Uta Oelschlaegel

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

Uwe Platzbecker, Martin Wermke, J. Radke et al. · Leukemia · 2011 · 391 citations · Full text

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Christoph Röllig, Christian Thiede, Martin Gramatzki et al. · Blood · 2010 · 175 citations · Full text

PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

Frank Pistrosch, Kay Herbrig, Uta Oelschlaegel et al. · Atherosclerosis · 2005 · 156 citations

Migratory Activity, Signal Transduction, Developmental Biology +8

Cytarabine Dose of 36 g/m² Compared With 12 g/m² Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study

Markus Schaich, Christoph Röllig, Silke Soucek et al. · Journal of Clinical Oncology · 2011 · 101 citations · Full text

Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis

Kay Herbrig, Frank Pistrosch, Uta Oelschlaegel et al. · American Journal of Kidney Diseases · 2004 · 98 citations

Hemodialysis, Urology, Medicine +10